Biodexa Pharmaceuticals Plc
BDRX
$1.55
-$0.01-0.64%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/24/2025
-
MarketBeat
4/24/2025
-
Zacks Investment Research
4/23/2025
-
MarketBeat
4/22/2025
-
MarketBeat
4/21/2025
-
MarketBeat
4/20/2025
-
MarketBeat
4/17/2025
-
MarketBeat
4/17/2025
-
Globe Newswire
4/16/2025
-
MarketBeat
4/15/2025
-
MarketBeat
4/14/2025
-
MarketBeat
4/11/2025
-
MarketBeat
4/11/2025
-
Globe Newswire
4/10/2025
-
MarketBeat
4/9/2025
-
MarketBeat
4/8/2025
-
MarketBeat
4/7/2025
-
MarketBeat
4/6/2025
-
MarketBeat
4/5/2025
-
MarketBeat
4/4/2025
-
MarketBeat
4/3/2025
-
MarketBeat
4/1/2025
-
MarketBeat
3/31/2025
-
MarketBeat
3/30/2025
-
MarketBeat
3/29/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, April 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Sep 22 and 26 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 29 2048 0180
Address
1 Caspian Point
Cardiff, CF10 4DQ
Cardiff, CF10 4DQ
Country
Year Founded
Business Description
Sector
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain...
more